1. A French approach to cost-effectiveness analysis?

   • Gérard de Pouvourville

   Editorial 03 November 2010 Pages: 521 - 523

2. The direct, indirect and intangible costs of visual impairment caused by neovascular age-related macular degeneration

   • Kathleen Melissa Ke

   Original Paper 21 November 2009 Pages: 525 - 531

3. Adolescents alcohol-use and economic conditions: a multilevel analysis of data from a period with big economic changes

   • Mikael Svensson
   • Curt Hagquist

   Original Paper 10 December 2009 Pages: 533 - 541

   

4. The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands

   • Marcus Richard Keogh-Brown
   • Richard D. Smith
   • Philippe Beutels

   Original Paper 09 December 2009 Pages: 543 - 554

   

5. The effect of health care expenditure on sickness absence

   • David Granlund

   Original Paper 06 January 2010 Pages: 555 - 568

   

6. The sustainability of public health expenditures: evidence from the Canadian federation

   • Livio Di Matteo

   Original Paper 12 January 2010 Pages: 569 - 584

   

7. The impact on schizophrenia-related hospital utilization and costs of switching to long-acting risperidone injections in Sweden

   • Michael Willis
   • Marianne Svensson
   • Ulf Persson

   Original Paper 19 January 2010 Pages: 585 - 594

   

8. On the welfare theoretic foundation of CEA: comment

   • Friedrich Breyer

   Original Paper 15 October 2010 Pages: 595 - 596

9. Cost-effectiveness analysis, welfare economics, and the societal perspective: a reply

   • Bengt Liljas

   Original Paper 19 October 2010 Pages: 597 - 598

10. Erratum to: Hospital’s activity-based financing system and manager–physician interaction

    • David Crainich
    • Hervé Leleu
    • Ana Mauleon

    Erratum 31 August 2010 Pages: 599 - 599